AMERICAN SHARED HOSPITAL SERVICES Cost of Revenue
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Cost of Revenue of $7.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-13
- AMERICAN SHARED HOSPITAL SERVICES cost of revenue for the quarter ending 2026-06-30 was $7.00M, a 28.60% increase year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES cost of revenue for the quarter ending 2026-03-31 was $5.80M, a 12.11% increase year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES cost of revenue for the quarter ending 2025-12-31 was $6.82M, a 16.32% increase year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES cost of revenue for the quarter ending 2025-09-30 was $5.58M, a 0.78% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES cost of revenue for fiscal 2025 was $23.02M, a 20.17% increase from fiscal 2024.
- AMERICAN SHARED HOSPITAL SERVICES cost of revenue for fiscal 2024 was $19.16M, a 59.88% increase from fiscal 2023.
- AMERICAN SHARED HOSPITAL SERVICES cost of revenue for fiscal 2023 was $11.98M, a 5.43% increase from fiscal 2022.
- AMERICAN SHARED HOSPITAL SERVICES cost of revenue for fiscal 2022 was $11.36M, a 4.24% increase from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.00M 10-Q · filed 2026-08-13 | $12.79M 10-Q · filed 2026-08-13 | $19.61M derived: sum of 3 quarters · filed 2026-08-13 | $25.20M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $5.80M 10-Q · filed 2026-05-14 | $12.62M derived: sum of 2 quarters · filed 2026-05-14 | $18.20M derived: sum of 3 quarters · filed 2026-05-14 | $23.64M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $6.82M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-31 | $12.41M derived: sum of 2 quarters · filed 2026-03-31 | $17.85M derived: sum of 3 quarters · filed 2026-08-13 | $23.02M 10-K · filed 2026-03-31 |
| 2025-09-30 | $5.58M 10-Q/A · filed 2026-01-16 | $11.03M derived: sum of 2 quarters · filed 2026-08-13 | $16.20M 10-Q/A · filed 2026-01-16 | $22.06M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $5.44M 10-Q · filed 2026-08-13 | $10.61M 10-Q · filed 2026-08-13 | $16.48M derived: sum of 3 quarters · filed 2026-08-13 | $22.11M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $5.17M 10-Q · filed 2026-05-14 | $11.04M derived: sum of 2 quarters · filed 2026-05-14 | $16.66M derived: sum of 3 quarters · filed 2026-05-14 | $21.25M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $5.87M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-31 | $11.49M derived: sum of 2 quarters · filed 2026-03-31 | $16.08M derived: sum of 3 quarters · filed 2026-03-31 | $19.16M 10-K · filed 2026-03-31 |
| 2024-09-30 | $5.63M 10-Q/A · filed 2026-01-16 | $10.22M derived: sum of 2 quarters · filed 2026-01-16 | $13.29M 10-Q/A · filed 2026-01-16 | $16.17M derived: sum of 4 quarters · filed 2026-01-16 |
| 2024-06-30 | $4.59M 10-Q · filed 2025-08-13 | $7.66M 10-Q · filed 2025-08-13 | $10.54M derived: sum of 3 quarters · filed 2025-08-13 | $13.57M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $3.07M 10-Q · filed 2025-05-15 | $5.96M derived: sum of 2 quarters · filed 2025-05-15 | $8.99M derived: sum of 3 quarters · filed 2025-05-15 | $12.04M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $2.88M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $5.91M derived: sum of 2 quarters · filed 2025-04-04 | $8.96M derived: sum of 3 quarters · filed 2025-04-04 | $11.98M 10-K · filed 2025-04-04 |
| 2023-09-30 | $3.03M 10-Q · filed 2023-11-14 | $6.08M derived: sum of 2 quarters · filed 2024-08-14 | $9.10M 10-Q · filed 2023-11-14 | $11.87M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-06-30 | $3.05M 10-Q · filed 2024-08-14 | $6.07M 10-Q · filed 2024-08-14 | $8.83M derived: sum of 3 quarters · filed 2024-08-14 | $11.71M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $3.02M 10-Q · filed 2024-05-15 | $5.78M derived: sum of 2 quarters · filed 2024-05-15 | $8.65M derived: sum of 3 quarters · filed 2024-05-15 | $11.60M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $5.64M derived: sum of 2 quarters · filed 2024-04-01 | $8.58M derived: sum of 3 quarters · filed 2024-04-01 | $11.36M 10-K · filed 2024-04-01 |
| 2022-09-30 | $2.87M 10-Q · filed 2023-11-14 | $5.82M derived: sum of 2 quarters · filed 2023-11-14 | $8.60M 10-Q · filed 2023-11-14 | $11.07M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $2.95M 10-Q · filed 2023-08-14 | $5.73M 10-Q · filed 2023-08-14 | $8.20M derived: sum of 3 quarters · filed 2023-08-14 | $10.83M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $2.78M 10-Q · filed 2023-05-12 | $5.25M derived: sum of 2 quarters · filed 2023-05-12 | $7.88M derived: sum of 3 quarters · filed 2023-05-12 | $10.75M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $2.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $5.10M derived: sum of 2 quarters · filed 2023-03-31 | $7.97M derived: sum of 3 quarters · filed 2023-03-31 | $10.90M 10-K · filed 2023-03-31 |
| 2021-09-30 | $2.63M 10-Q · filed 2022-11-10 | $5.50M derived: sum of 2 quarters · filed 2022-11-10 | $8.43M 10-Q · filed 2022-11-10 | $12.01M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $2.87M 10-Q · filed 2022-08-15 | $5.80M 10-Q · filed 2022-08-15 | $9.38M derived: sum of 3 quarters · filed 2022-08-15 | $12.91M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $2.93M 10-Q · filed 2022-05-12 | $6.51M derived: sum of 2 quarters · filed 2022-05-12 | $10.04M derived: sum of 3 quarters · filed 2022-05-12 | $13.13M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $3.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $7.11M derived: sum of 2 quarters · filed 2022-03-30 | $10.20M derived: sum of 3 quarters · filed 2022-03-30 | $13.37M 10-K · filed 2022-03-30 |
| 2020-09-30 | $3.53M 10-Q · filed 2021-11-10 | $6.62M derived: sum of 2 quarters · filed 2021-11-10 | $9.79M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $3.08M 10-Q · filed 2021-08-12 | $6.26M 10-Q · filed 2021-08-12 | ||
| 2019-09-30 | $3.49M 10-Q · filed 2019-11-07 | $6.96M derived: sum of 2 quarters · filed 2019-11-07 | $10.34M 10-Q · filed 2019-11-07 | $13.54M derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | $3.47M 10-Q · filed 2019-08-13 | $6.85M 10-Q · filed 2019-08-13 | $10.06M derived: sum of 3 quarters · filed 2019-08-13 | $12.89M derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-03-31 | $3.38M 10-Q · filed 2019-05-13 | $6.59M derived: sum of 2 quarters · filed 2019-05-13 | $9.43M derived: sum of 3 quarters · filed 2019-11-07 | $12.51M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-12-31 | $3.21M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $6.04M derived: sum of 2 quarters · filed 2019-11-07 | $9.13M derived: sum of 3 quarters · filed 2019-11-07 | $12.23M 10-K · filed 2019-03-29 |
| 2018-09-30 | $2.84M 10-Q · filed 2019-11-07 | $5.92M derived: sum of 2 quarters · filed 2019-11-07 | $9.02M 10-Q · filed 2019-11-07 | $11.92M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $3.09M 10-Q · filed 2019-08-13 | $6.19M 10-Q · filed 2019-08-13 | $9.09M derived: sum of 3 quarters · filed 2019-08-13 | $11.82M derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | $3.10M 10-Q · filed 2019-05-13 | $6.00M derived: sum of 2 quarters · filed 2019-05-13 | $8.73M derived: sum of 3 quarters · filed 2019-05-13 | $11.42M derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | $2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $5.63M derived: sum of 2 quarters · filed 2019-03-29 | $8.32M derived: sum of 3 quarters · filed 2019-03-29 | $10.89M 10-K · filed 2019-03-29 |
| 2017-09-30 | $2.73M 10-Q · filed 2018-11-09 | $5.42M derived: sum of 2 quarters · filed 2018-11-09 | $7.99M 10-Q · filed 2018-11-09 | $10.23M derived: sum of 4 quarters · filed 2019-03-29 |
| 2017-06-30 | $2.69M 10-Q · filed 2018-08-09 | $5.26M 10-Q · filed 2018-08-09 | $7.50M derived: sum of 3 quarters · filed 2019-03-29 | $9.98M derived: sum of 4 quarters · filed 2019-03-29 |
| 2017-03-31 | $2.57M 10-Q · filed 2018-05-10 | $4.80M derived: sum of 2 quarters · filed 2019-03-29 | $7.29M derived: sum of 3 quarters · filed 2019-03-29 | $9.97M derived: sum of 4 quarters · filed 2019-03-29 |
| 2016-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $4.72M derived: sum of 2 quarters · filed 2019-03-29 | $7.40M derived: sum of 3 quarters · filed 2019-03-29 | $9.90M 10-K · filed 2019-03-29 |
| 2016-09-30 | $2.49M 10-Q · filed 2017-11-13 | $5.17M derived: sum of 2 quarters · filed 2017-11-13 | $7.67M 10-Q · filed 2017-11-13 | $9.97M derived: sum of 4 quarters · filed 2018-03-28 |
| 2016-06-30 | $2.68M 10-Q · filed 2017-08-10 | $5.18M 10-Q · filed 2017-08-10 | $7.48M derived: sum of 3 quarters · filed 2018-03-28 | $9.90M derived: sum of 4 quarters · filed 2018-03-28 |
| 2016-03-31 | $2.50M 10-Q · filed 2017-05-15 | $4.80M derived: sum of 2 quarters · filed 2018-03-28 | $7.23M derived: sum of 3 quarters · filed 2018-03-28 | $9.82M derived: sum of 4 quarters · filed 2018-03-28 |
| 2015-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $4.72M derived: sum of 2 quarters · filed 2018-03-28 | $7.31M derived: sum of 3 quarters · filed 2018-03-28 | $9.83M 10-K · filed 2018-03-28 |
| 2015-09-30 | $2.42M 10-Q · filed 2016-11-10 | $5.01M derived: sum of 2 quarters · filed 2016-11-10 | $7.53M 10-Q · filed 2016-11-10 | $9.98M derived: sum of 4 quarters · filed 2017-03-27 |
| 2015-06-30 | $2.59M 10-Q · filed 2016-08-11 | $5.11M 10-Q · filed 2016-08-11 | $7.56M derived: sum of 3 quarters · filed 2017-03-27 | $9.94M derived: sum of 4 quarters · filed 2017-03-27 |
| 2015-03-31 | $2.52M 10-Q · filed 2016-05-12 | $4.97M derived: sum of 2 quarters · filed 2017-03-27 | $7.35M derived: sum of 3 quarters · filed 2017-03-27 | $9.88M derived: sum of 4 quarters · filed 2017-03-27 |
| 2014-12-31 | $2.45M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | $4.83M derived: sum of 2 quarters · filed 2017-03-27 | $7.36M derived: sum of 3 quarters · filed 2017-03-27 | $10.14M 10-K · filed 2017-03-27 |
| 2014-09-30 | $2.38M 10-Q · filed 2015-11-12 | $4.91M derived: sum of 2 quarters · filed 2015-11-12 | $7.69M 10-Q · filed 2015-11-12 | $10.27M derived: sum of 4 quarters · filed 2016-03-30 |
| 2014-06-30 | $2.53M 10-Q · filed 2015-08-19 | $5.31M 10-Q · filed 2015-08-19 | $7.89M derived: sum of 3 quarters · filed 2016-03-30 | $10.71M derived: sum of 4 quarters · filed 2016-03-30 |
| 2014-03-31 | $2.77M 10-Q · filed 2015-05-14 | $5.36M derived: sum of 2 quarters · filed 2016-03-30 | $8.18M derived: sum of 3 quarters · filed 2016-03-30 | $10.87M derived: sum of 4 quarters · filed 2016-03-30 |
| 2013-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $5.40M derived: sum of 2 quarters · filed 2016-03-30 | $8.09M derived: sum of 3 quarters · filed 2016-03-30 | $10.64M 10-K · filed 2016-03-30 |
| 2013-09-30 | $2.81M 10-Q · filed 2014-11-14 | $5.50M derived: sum of 2 quarters · filed 2014-11-14 | $8.05M 10-Q · filed 2014-11-14 | $10.65M derived: sum of 4 quarters · filed 2015-04-01 |
| 2013-06-30 | $2.69M 10-Q · filed 2014-08-15 | $5.24M 10-Q · filed 2014-08-15 | $7.84M derived: sum of 3 quarters · filed 2015-04-01 | $10.38M derived: sum of 4 quarters · filed 2015-04-01 |
| 2013-03-31 | $2.55M 10-Q · filed 2014-05-15 | $5.15M derived: sum of 2 quarters · filed 2015-04-01 | $7.69M derived: sum of 3 quarters · filed 2015-04-01 | $10.10M derived: sum of 4 quarters · filed 2015-04-01 |
| 2012-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-01 | $5.14M derived: sum of 2 quarters · filed 2015-04-01 | $7.55M derived: sum of 3 quarters · filed 2015-04-01 | $10.12M 10-K · filed 2015-04-01 |
| 2012-09-30 | $2.54M 10-Q · filed 2013-11-14 | $4.95M derived: sum of 2 quarters · filed 2013-11-14 | $7.52M 10-Q · filed 2013-11-14 | $10.24M derived: sum of 4 quarters · filed 2014-03-31 |
| 2012-06-30 | $2.41M 10-Q · filed 2013-08-14 | $4.98M 10-Q · filed 2013-08-14 | $7.70M derived: sum of 3 quarters · filed 2014-03-31 | $14.39M derived: sum of 4 quarters · filed 2014-03-31 |
| 2012-03-31 | $2.57M 10-Q · filed 2013-05-15 | $5.29M derived: sum of 2 quarters · filed 2014-03-31 | $11.98M derived: sum of 3 quarters · filed 2014-03-31 | $14.35M derived: sum of 4 quarters · filed 2014-03-31 |
| 2011-12-31 | $2.72M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $9.41M derived: sum of 2 quarters · filed 2014-03-31 | $11.78M derived: sum of 3 quarters · filed 2014-03-31 | $14.22M 10-K · filed 2014-03-31 |
| 2011-09-30 | $6.69M 10-Q · filed 2012-11-14 | $9.06M derived: sum of 2 quarters · filed 2012-11-14 | $11.50M 10-Q · filed 2012-11-14 | $13.74M derived: sum of 4 quarters · filed 2013-03-29 |
| 2011-06-30 | $2.37M 10-Q/A · filed 2012-09-07 | $4.81M 10-Q/A · filed 2012-09-07 | $7.05M derived: sum of 3 quarters · filed 2013-03-29 | $9.48M derived: sum of 4 quarters · filed 2013-03-29 |
| 2011-03-31 | $2.44M 10-Q · filed 2012-05-15 | $4.68M derived: sum of 2 quarters · filed 2013-03-29 | $7.12M derived: sum of 3 quarters · filed 2013-03-29 | $9.52M derived: sum of 4 quarters · filed 2013-03-29 |
| 2010-12-31 | $2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | $4.67M derived: sum of 2 quarters · filed 2013-03-29 | $7.08M derived: sum of 3 quarters · filed 2013-03-29 | $9.47M 10-K · filed 2013-03-29 |
| 2010-09-30 | $2.44M 10-Q · filed 2011-11-14 | $4.84M derived: sum of 2 quarters · filed 2011-11-14 | $7.23M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $2.40M 10-Q/A · filed 2011-10-24 | $4.79M 10-Q/A · filed 2011-10-24 | ||
| 2009-12-31 | $9.78M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |